PDA Publishes Results of Transportation Validation Benchmarking Survey
Recommendation
Wednesday, 18 February 2026 9 .00 - 17.30 h
How to Audit Logistics Service Providers
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In June 2025, the Parenteral Drug Association (PDA) published the results of its 2025 Transportation Validation Benchmarking Survey.
The PDA writes: "This survey aimed to gather industry benchmarking data on transportation qualification strategies within the pharmaceutical and biopharmaceutical industry. Specifically, the goal was to examine the application of simulated data to better understand how transportation conditions impact drug product quality, emphasizing the importance of ensuring product quality during transit. The survey focused on evaluating transportation through simulated environments versus real-world qualification of temperature-controlled shipping systems. [...]
To contextualize responses, the survey included general demographic questions and was structured into product-specific, supply-chain-focused, and regulatory strategy-driven categories. The manufacturers of small molecule medicines and oral dosage forms were not a target audience for this survey."
The full 40-page report (PDA Item No. 8363) is available as a PDF download on the PDA website. The price is $180 for members and $325 for nonmembers. Premium members can request a free copy until 17 July 2025.
Related GMP News
11.11.2025Supply Chains in 2035
11.11.2025Questions and Answers on Transport and Vehicle Qualification (Part 1)
14.10.2025MHRA Blog Post: GDP in the Aviation and Marine Sectors
14.10.2025Commercial GDP Certificates: Helpful Tool or Questionable Assurance?
14.10.2025Mean Kinetic Temperature (MKT): Calculation, Benefits, and Limitations
14.10.2025Fiscal Importation within the EEA - Discussion of ECA GDP Survey Results